Target Price | HKD9.79 |
Price | HKD9.69 |
Potential |
1.05%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Grand Pharmaceutical 2026 .
The average Grand Pharmaceutical target price is HKD9.79.
This is
1.05%
register free of charge
HKD10.66
9.98%
register free of charge
HKD6.26
35.38%
register free of charge
|
|
A rating was issued by 8 analysts: 7 Analysts recommend Grand Pharmaceutical to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Grand Pharmaceutical stock has an average upside potential 2026 of
1.05%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion HKD | 11.64 | 12.37 |
10.59% | 6.21% | |
EBITDA Margin | 23.39% | 22.53% |
24.25% | 3.66% | |
Net Margin | 21.20% | 17.17% |
18.72% | 19.00% |
5 Analysts have issued a sales forecast Grand Pharmaceutical 2025 . The average Grand Pharmaceutical sales estimate is
This results in the following potential growth metrics:
5 Grand Pharmaceutical Analysts have issued a net profit forecast 2025. The average Grand Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.70 | 0.61 |
29.63% | 12.86% | |
P/E | 15.98 | |
EV/Sales | 2.92 |
5 Analysts have issued a Grand Pharmaceutical forecast for earnings per share. The average Grand Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Grand Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.